BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 35611632)

  • 1. Bleeding patterns of women with heavy menstrual bleeding or dysmenorrhoea using the levonorgestrel-releasing intrauterine system: results from a real-world observational study in Japan (J-MIRAI).
    Kitawaki J; Akira S; Harada T; Maeda N; Momoeda M; Ota I; Murakami T; Sunaya T; Hirano K
    Eur J Contracept Reprod Health Care; 2022 Aug; 27(4):300-307. PubMed ID: 35611632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Predicting Removals of the Levonorgestrel-Releasing Intrauterine System in an Adolescent Cohort.
    Baum A; Chan K; Sachedina A; Grover SR
    J Pediatr Adolesc Gynecol; 2024 Apr; 37(2):171-176. PubMed ID: 38128876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heavy menstrual bleeding in women with inherited bleeding disorders in use of LNG-IUS: A systematic review and single-arm meta-analysis.
    Oliveira JA; Eskandar K; Chagas J; do Nascimento LLO; Ribeiro DD; Rocha ALL; de Oliveira FR
    Contraception; 2024 Jul; 135():110450. PubMed ID: 38614274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia.
    Sayed GH; Zakherah MS; El-Nashar SA; Shaaban MM
    Int J Gynaecol Obstet; 2011 Feb; 112(2):126-30. PubMed ID: 21092958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does a Bleeding Disorder Lessen the Efficacy of the 52-mg Levonorgestrel-Releasing Intrauterine System for Heavy Menstrual Bleeding in Adolescents? A Retrospective Multicenter Study.
    Khalighi M; Wheeler AP; Adeyemi-Fowode OA; Kouides PA; Durazo-Arvizu RA; Haley K; Dersch CM; Weyand AC; Baldwin MK; Borzutzky C
    J Adolesc Health; 2022 Aug; 71(2):204-209. PubMed ID: 35430143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of efficacy between levonorgestrel intrauterine system and dienogest in adenomyosis: a randomized clinical trial.
    Choudhury S; Jena SK; Mitra S; Padhy BM; Mohakud S
    Ther Adv Reprod Health; 2024; 18():26334941241227401. PubMed ID: 38283750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of mixed-treatment-comparison methods in estimating efficacy of treatments for heavy menstrual bleeding.
    Hoaglin DC; Filonenko A; Glickman ME; Wasiak R; Gidwani R
    Eur J Med Res; 2013 Jun; 18(1):17. PubMed ID: 23786677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleeding profile and safety of a levonorgestrel 13.5 mg intrauterine device versus Nova T copper 380 mm
    Perelló-Capó J; Estadella-Tarriel J; Gich-Saladich I; Bailón-Queiruga M; Llurba-Olivé E; Calaf-Alsina J
    Contraception; 2023 Nov; 127():110127. PubMed ID: 37487868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial comparing the 52-mg levonorgestrel system with combination oral contraceptives for treatment of heavy menstrual bleeding.
    Matteson KA; Valcin J; Raker CA; Clark MA
    Am J Obstet Gynecol; 2023 Nov; 229(5):532.e1-532.e13. PubMed ID: 37536486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of etonogestrel subcutaneous implants versus the levonorgestrel-releasing intrauterine system in the conservative treatment of adenomyosis.
    Wei A; Tang X; Yang W; Zhou J; Zhu W; Pan S
    Open Med (Wars); 2024; 19(1):20240914. PubMed ID: 38584829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral micronised flavonoids versus tranexamic acid for treatment of heavy menstrual bleeding secondary to copper IUD use: a randomised double-blind clinical trial.
    Alanwar A; Abbas AM; Hussain SH; Elhawwary G; Mansour DY; Faisal MM; Elshabrawy A; Eltaieb E
    Eur J Contracept Reprod Health Care; 2018 Oct; 23(5):365-370. PubMed ID: 30247074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Levonorgestrel Intrauterine System in the Management of Abnormal Uterine Bleeding: A Retrospective Analysis of a 100 Women.
    Ganatra A; Shah F; Ganatra K
    J Obstet Gynaecol India; 2024 Feb; 74(1):67-70. PubMed ID: 38434135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ulipristal acetate versus levonorgestrel-releasing intrauterine system for heavy menstrual bleeding (UCON): a randomised controlled phase III trial.
    Whitaker LHR; Middleton LJ; Daniels JP; Williams ARW; Priest L; Odedra S; Cheed V; Stubbs CE; Clark TJ; Lumsden MA; Hapangama DK; Bhattacharya S; Smith PP; Nicholls EP; Roberts N; Semple SI; Saraswat L; Walker J; Chodankar RR; Critchley HOD;
    EClinicalMedicine; 2023 Jun; 60():101995. PubMed ID: 37251622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose letrozole - an effective option for women with symptomatic adenomyosis awaiting IVF: a pilot randomized controlled trial.
    Sharma S; RoyChoudhury S; Bhattacharya MP; Hazra S; Majhi AK; Oswal KC; Chattopadhyay R
    Reprod Biomed Online; 2023 Jul; 47(1):84-93. PubMed ID: 37149412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mobile Application Measurement of Menstrual Cycle Characteristics and Their Association with Dysmenorrhea and Activity Limitation in Early Adolescents.
    Bala NS; Vesely SK; Bonny AE; Chisholm JC; Sezgin E; Beeman C; McCracken K; O'Brien SH
    J Pediatr Adolesc Gynecol; 2024 Apr; 37(2):126-131. PubMed ID: 37863175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenomyosis diagnosis among adolescents and young women with dysmenorrhoea and heavy menstrual bleeding.
    Vannuccini S; Meleca C; Toscano F; Mertino P; Pampaloni F; Fambrini M; Bruni V; Petraglia F
    Reprod Biomed Online; 2024 May; 48(5):103768. PubMed ID: 38432071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical therapy versus radiofrequency endometrial ablation in the initial treatment of heavy menstrual bleeding (iTOM Trial): A clinical and economic analysis.
    Famuyide AO; Laughlin-Tommaso SK; Shazly SA; Hall Long K; Breitkopf DM; Weaver AL; McGree ME; El-Nashar SA; Lemens MA; Hopkins MR
    PLoS One; 2017; 12(11):e0188176. PubMed ID: 29141040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ISTH-BAT score and outcomes after endometrial ablation in women with heavy menstrual bleeding.
    Eising HP; Punt MC; Schermer T; Leemans JC; Bongers MY
    Haemophilia; 2023 Nov; 29(6):1573-1579. PubMed ID: 37758646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Instruments to Identify Menstrual Complaints and Their Impact on Adolescents: A Systematic Review.
    Özcan H; Burger NB; Dulmen-den Broeder EV; van Baal MW; den Boogaard EV; De Leeuw RA; Huirne JAF
    J Pediatr Adolesc Gynecol; 2024 Apr; 37(2):106-120. PubMed ID: 38104798
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.